Cite
MLA Citation
G. Martinelli et al.. “P520: PHASE 1/2 STUDY OF SEL24/MEN1703, A FIRST-IN-CLASS DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH IDH1/2-MUTATED ACUTE MYELOID LEUKEMIA: THE DIAMOND-01 TRIAL..” HemaSphere, vol. 6, n.d., pp. 419–420. http://access.bl.uk/ark:/81055/vdc_100159757216.0x000011